1. Home
  2. VSME vs ANL Comparison

VSME vs ANL Comparison

Compare VSME & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSME
  • ANL
  • Stock Information
  • Founded
  • VSME 2013
  • ANL 2004
  • Country
  • VSME Hong Kong
  • ANL Cayman Islands
  • Employees
  • VSME N/A
  • ANL N/A
  • Industry
  • VSME
  • ANL
  • Sector
  • VSME
  • ANL
  • Exchange
  • VSME Nasdaq
  • ANL Nasdaq
  • Market Cap
  • VSME 56.9M
  • ANL 61.8M
  • IPO Year
  • VSME 2023
  • ANL 2023
  • Fundamental
  • Price
  • VSME $1.42
  • ANL $1.68
  • Analyst Decision
  • VSME
  • ANL Hold
  • Analyst Count
  • VSME 0
  • ANL 1
  • Target Price
  • VSME N/A
  • ANL N/A
  • AVG Volume (30 Days)
  • VSME 1.7M
  • ANL 9.2K
  • Earning Date
  • VSME 01-01-0001
  • ANL 10-31-2025
  • Dividend Yield
  • VSME N/A
  • ANL N/A
  • EPS Growth
  • VSME N/A
  • ANL N/A
  • EPS
  • VSME N/A
  • ANL N/A
  • Revenue
  • VSME $8,248,108.00
  • ANL N/A
  • Revenue This Year
  • VSME N/A
  • ANL N/A
  • Revenue Next Year
  • VSME N/A
  • ANL N/A
  • P/E Ratio
  • VSME N/A
  • ANL N/A
  • Revenue Growth
  • VSME 3.22
  • ANL N/A
  • 52 Week Low
  • VSME $0.51
  • ANL $1.10
  • 52 Week High
  • VSME $3.69
  • ANL $3.89
  • Technical
  • Relative Strength Index (RSI)
  • VSME 32.88
  • ANL 48.54
  • Support Level
  • VSME $1.15
  • ANL $1.60
  • Resistance Level
  • VSME $1.48
  • ANL $1.73
  • Average True Range (ATR)
  • VSME 0.35
  • ANL 0.08
  • MACD
  • VSME -0.11
  • ANL -0.01
  • Stochastic Oscillator
  • VSME 12.71
  • ANL 48.60

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: